Eli Lilly became the most valuable health-care company in the world on the back of its blockbuster diabetes and obesity drugs.
The billions of dollars in Eli Lilly is investing in manufacturing capacity support the idea that the long-term opportunity is immense.
Adding Eli Lilly to the market could help address some of the obstacles that limited Leqembi's sales early on.
Eli Lilly, which has spent billions in search of a successful Alzheimer's treatment , had hoped for donanemab to be approved by now.
A sign with the company logo sits outside of the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana.
Persons:
Eli Lilly, donanemab, Eli Lilly's, Donanemab, Leqembi —, Biogen, —, Jim Cramer's, Ken Langone, Morgan Stanley, Cantor Fitzgerald, Leqembi, Jim Cramer, Jim, Scott Olson
Organizations:
Food and Drug Administration, FactSet, Novo Nordisk, FDA, GE Healthcare, CNBC, Company, Getty
Locations:
GLP, Indianapolis , Indiana